IBO logo

IMPACT BIOMEDICAL INC

IBONYSE AMERICAN
๐Ÿ† #4153 by market capUS Equity
$6.17โ–ฒ $1.20 (+24.14%)
Market closed ยท at close
๐Ÿ””
Track IBO
Get earnings, price moves & breaking news on Telegram
Track
24hโ–ฒ 24.1%
7dโ–ฒ 50.1%
14dโ–ฒ 50.1%
30dโ–ฒ 97.1%
ytdโ–ฒ 4.6%
1yโ–ฒ 11.6%
๐ŸฆMarket Cap
$53M
Small Cap
๐Ÿ“ˆRevenue Growth (YoY)
โ€”
๐Ÿ“ŠGross Margin
82.1%
High
๐Ÿ’ตFCF Margin
โ€”
โš–๏ธP/S Ratio
1523.1x
Expensive
Otter Score
โ€”
Insufficient data

Trading Snapshot

Day Range
$6.17 โ€“ $6.21
52-Week Range
$2.43 โ€“ $10.47
Volume (shares)
294
Avg Volume (shares)
โ€”
Shares Outstanding
8.5M
Next Earnings
โ€”

Fundamentals Snapshot

Annual Revenue
$32,000
Last Q Revenue
$21,000
P/E Ratio
67.6
P/S Ratio
1523.1x
EPS (TTM)
$-0.09
Dividend Yield
โ€”
IBO logo

IMPACT BIOMEDICAL INC

IBO
Financial Trends

Financial history unavailable.

StockOtter ยท stockotter.space

About IMPACT BIOMEDICAL INC

Houston, Texas-based Impact BioMedical Inc., founded in 2018, focuses on discovering and developing innovative products and therapeutic options for both specialty biopharmaceuticals and consumer healthcare markets. The company features several key technologies: its "Linebacker" platform utilizes small molecule electrophilically enhanced polyphenol compounds with potential applications in treating cancer, inflammatory diseases, and neurological conditions. Additionally, "Laetose" technology, a unique blend of sugar and inositol, is designed to counteract the inflammatory and metabolic responses usually triggered by sugar consumption. Impact BioMedical also creates "functional fragrance formulations," which are a series of fragrances incorporating specialized botanical ingredients for antimicrobial purposes, or as active additives in items like insect repellents, cleaning products, personal care items, and fabrics. Rounding out its offerings is the "Equivir/Equivir G" technology, a distinctive mix of polyphenols that has exhibited antiviral properties, suitable for use in health supplements and medications.

๐Ÿฆฆ

Otter Score Breakdown

How it's scoredFive components, each rated 1โ€“5โ˜… and equally weighted (20%), averaged to a 0โ€“100 score:๐Ÿ’Ž Quality โ€” gross margin๐Ÿš€ Growth โ€” revenue YoYโš–๏ธ Valuation โ€” P/S ratioโšก Momentum โ€” 30-day price change๐Ÿ’ง Dilution โ€” 1-yr share issuance (buybacks score higher)

Insufficient data for all five components.

๐Ÿ’ŽQualityโ˜…โ˜…โ˜…โ˜…โ˜…
โš–๏ธValuationโ˜…โ˜…โ˜…โ˜…โ˜…
Overall Score
Insufficient data
โ€”/100
Analyst data unavailable.

Latest News & Updates

News unavailable.